Treatment effect of intravenous high-dose selenium in sepsis phenotypes: a retrospective analysis of a large multicenter randomized controlled trial
David I. Radke, Holger Bogatsch, Christian Stoppe(Universitätsklinikum Würzburg), Frank Bloos(Jena University Hospital), Anna Lulu Homayr(University Hospital Schleswig-Holstein), Christoph Engel(University Hospital Leipzig), Matthias Lindner(Christian-Albrechts-Universität zu Kiel), Michael Bauer(Jena University Hospital), Patrick Meybohm(Universitätsklinikum Würzburg), Gunnar Elke
Cited by 1
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
|Nature Genetics|2010|734
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
|Intensive Care Medicine|2007|623